DK3630092T3 - Formulering på basis af vitamin E eller en ester deraf til behandling af bakterie- og svampebiofilm - Google Patents
Formulering på basis af vitamin E eller en ester deraf til behandling af bakterie- og svampebiofilm Download PDFInfo
- Publication number
- DK3630092T3 DK3630092T3 DK18727014.5T DK18727014T DK3630092T3 DK 3630092 T3 DK3630092 T3 DK 3630092T3 DK 18727014 T DK18727014 T DK 18727014T DK 3630092 T3 DK3630092 T3 DK 3630092T3
- Authority
- DK
- Denmark
- Prior art keywords
- vitamin
- bacterial
- ester
- treatment
- formulation based
- Prior art date
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title 2
- 229930003427 Vitamin E Natural products 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 230000002538 fungal effect Effects 0.000 title 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229940046009 vitamin E Drugs 0.000 title 1
- 235000019165 vitamin E Nutrition 0.000 title 1
- 239000011709 vitamin E Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000058311A IT201700058311A1 (it) | 2017-05-29 | 2017-05-29 | Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini |
| PCT/EP2018/063926 WO2018219862A1 (en) | 2017-05-29 | 2018-05-28 | Formulation based on vitamin e or an ester thereof for treating bacterial and fungal biofilms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3630092T3 true DK3630092T3 (da) | 2022-06-20 |
Family
ID=60294053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18727014.5T DK3630092T3 (da) | 2017-05-29 | 2018-05-28 | Formulering på basis af vitamin E eller en ester deraf til behandling af bakterie- og svampebiofilm |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US20200360339A1 (da) |
| EP (1) | EP3630092B1 (da) |
| CN (1) | CN110650737A (da) |
| AU (1) | AU2018275487B2 (da) |
| BR (1) | BR112019023962A8 (da) |
| CA (1) | CA3061568C (da) |
| CL (1) | CL2019003254A1 (da) |
| CY (1) | CY1125414T1 (da) |
| DK (1) | DK3630092T3 (da) |
| EA (1) | EA201992190A1 (da) |
| ES (1) | ES2919423T3 (da) |
| GE (2) | GEP20207179B (da) |
| HR (1) | HRP20220808T1 (da) |
| HU (1) | HUE059185T2 (da) |
| IT (1) | IT201700058311A1 (da) |
| LT (1) | LT3630092T (da) |
| MA (1) | MA48936B1 (da) |
| MX (1) | MX389883B (da) |
| PL (1) | PL3630092T3 (da) |
| PT (1) | PT3630092T (da) |
| RS (1) | RS63347B1 (da) |
| SI (1) | SI3630092T1 (da) |
| SM (1) | SMT202200274T1 (da) |
| WO (1) | WO2018219862A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700058311A1 (it) * | 2017-05-29 | 2018-11-29 | Bio Lo Ga Srl | Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini |
| WO2021228849A1 (en) * | 2020-05-11 | 2021-11-18 | Katholieke Universiteit Leuven | Use of di- and tricarboxylic fatty acids in the prevention of biofilm formation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3755558A (en) * | 1971-02-23 | 1973-08-28 | Du Pont | Polylactide drug mixtures for topical application atelet aggregation |
| JPH09169643A (ja) * | 1995-12-22 | 1997-06-30 | Sekisui Chem Co Ltd | 寄生性皮膚疾患治療用外用剤 |
| IT1302275B1 (it) * | 1998-09-25 | 2000-09-05 | Giorgio Panin | Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica. |
| EP2418945B1 (en) * | 2009-04-15 | 2018-12-05 | BMG PHARMA S.p.A. | Mineral salt-sulfonic acid compositions and methods of use |
| ITUB20153889A1 (it) * | 2015-09-25 | 2017-03-25 | Bio Lo Ga Srl | Gel idrofobico a base di vitamina E esente da prodotti siliconici per applicazione topica |
| ITUB20169882A1 (it) * | 2016-01-08 | 2017-07-08 | Flame S R L | Vitamina E per l’uso nel trattamento e nella prevenzione delle infezioni da biofilm. |
| IT201700058311A1 (it) * | 2017-05-29 | 2018-11-29 | Bio Lo Ga Srl | Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini |
-
2017
- 2017-05-29 IT IT102017000058311A patent/IT201700058311A1/it unknown
-
2018
- 2018-05-28 BR BR112019023962A patent/BR112019023962A8/pt not_active Application Discontinuation
- 2018-05-28 SI SI201830680T patent/SI3630092T1/sl unknown
- 2018-05-28 AU AU2018275487A patent/AU2018275487B2/en active Active
- 2018-05-28 MX MX2019013559A patent/MX389883B/es unknown
- 2018-05-28 GE GEAP201815201A patent/GEP20207179B/en unknown
- 2018-05-28 EP EP18727014.5A patent/EP3630092B1/en active Active
- 2018-05-28 ES ES18727014T patent/ES2919423T3/es active Active
- 2018-05-28 HR HRP20220808TT patent/HRP20220808T1/hr unknown
- 2018-05-28 MA MA48936A patent/MA48936B1/fr unknown
- 2018-05-28 CA CA3061568A patent/CA3061568C/en active Active
- 2018-05-28 DK DK18727014.5T patent/DK3630092T3/da active
- 2018-05-28 HU HUE18727014A patent/HUE059185T2/hu unknown
- 2018-05-28 RS RS20220631A patent/RS63347B1/sr unknown
- 2018-05-28 WO PCT/EP2018/063926 patent/WO2018219862A1/en not_active Ceased
- 2018-05-28 PL PL18727014.5T patent/PL3630092T3/pl unknown
- 2018-05-28 US US16/613,526 patent/US20200360339A1/en not_active Abandoned
- 2018-05-28 PT PT187270145T patent/PT3630092T/pt unknown
- 2018-05-28 CN CN201880027971.1A patent/CN110650737A/zh active Pending
- 2018-05-28 GE GEAP202015201A patent/GEAP202015201A/en unknown
- 2018-05-28 EA EA201992190A patent/EA201992190A1/ru unknown
- 2018-05-28 LT LTEPPCT/EP2018/063926T patent/LT3630092T/lt unknown
- 2018-05-28 SM SM20220274T patent/SMT202200274T1/it unknown
-
2019
- 2019-11-13 CL CL2019003254A patent/CL2019003254A1/es unknown
- 2019-11-14 US US16/683,684 patent/US11234958B2/en active Active
-
2021
- 2021-04-15 US US17/231,761 patent/US20210228541A1/en not_active Abandoned
-
2022
- 2022-07-12 CY CY20221100480T patent/CY1125414T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3501542T3 (da) | Esketamin til behandling af depression | |
| PL3523053T3 (pl) | Urządzenie do powlekania i przynależny sposób eksploatacji | |
| DK3470519T3 (da) | Hidtil ukendte crispr-enzymer og -systemer | |
| LT3394259T (lt) | Tau raiškos mažinimo kompozicijos ir metodai | |
| EP3431561A4 (en) | HIGHLY RESISTANT SEAL-RESISTANT FILM AND COATING COMPOSITION | |
| BR112017005504A2 (pt) | composições que compreendem células recombinantes de bacillus e um inseticida. | |
| PL3293188T3 (pl) | Silany i utwardzalne kompozycje obejmujące wskazane silany | |
| DK3456787T3 (da) | Vandbaseret coatingformulering | |
| EP3426244C0 (en) | 3-phosphoglycerate dehydrogenase inhibitors and uses thereof | |
| EP3310374A4 (en) | GLUTATHION FORMULATION AND METHOD OF USE | |
| EP3604821A4 (en) | HELICOIDAL FAN | |
| DK3710036T3 (da) | Stable ascorbic acid compositions and methods of using the same | |
| EP3656830A4 (en) | ADHESIVE COMPOSITION AND ADHESIVE FILM | |
| EP3884939C0 (en) | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND THEIR USES | |
| BR112016020181A2 (pt) | Composições de ácido lipoico éster colina e métodos de uso. | |
| EP3610219A4 (en) | DYNAMIC AUTOPILOT | |
| EP3524278A4 (en) | EXPANDABLE FILM AND ITEM THEREFOR | |
| EP3473860A4 (en) | TURBINE AND AXIAL FAN | |
| EP3517581A4 (en) | COATING COMPOSITION, COATING FILM, AND COATING PROCESS | |
| EP3586011A4 (en) | IMPROVEMENTS MADE TO FANS | |
| EP3601223A4 (en) | ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULPHONIC ACID DERIVATIVES AND THEIR USES | |
| EP3553104A4 (en) | POLYISOCYANATE COMPOSITION AND COATING COMPOSITION | |
| EP3594285A4 (en) | COMPOSITION, AND COATING FILM | |
| EP3689977A4 (en) | COATING COMPOSITION AND COATING FILM | |
| EP3638322A4 (en) | DECONTAMINATION FORMULATION |